Preferred Label : serine proteases;

MeSH definition : Peptide hydrolases that contain at the active site a SERINE residue involved in catalysis.;

MeSH synonym : Proteases, Serine; Serine Proteinases; Proteinases, Serine; Serine Proteinase; Proteinase, Serine; Serine Protease; Protease, Serine; Serine Protein Hydrolases; Protein Hydrolases, Serine;

MeSH Related Number : EC 3.4.-;

Registry Number MeSH : EC 3.4.-;

MeSH annotation : do not confuse with SERINE ENDOPEPTIDASES;

Wikipedia link : https://en.wikipedia.org/wiki/Serine protease;

Is substance : O;

Details


Main resources

You can consult :

Peptide hydrolases that contain at the active site a SERINE residue involved in catalysis.

https://www.has-sante.fr/jcms/c_2859880/fr/brineura
https://www.has-sante.fr/jcms/c_2859880/fr/brineura-cerliponase-alfa-classe-simple
2018
false
false
false
France
French
treatment outcome
treatment outcome
recombinant proteins
recombinant proteins
TPP1 protein, human
TPP1 protein, human
ceroid lipofuscinosis, neuronal, 2
ceroid lipofuscinosis, neuronal, 2
infusions, intraventricular
infusions, intraventricular
infant, newborn
infant, newborn
infant
infant
child
child
cerliponase alfa
cerliponase alfa
evaluation of the transparency committee
evaluation of the transparency committee
orphan drug production
orphan drug production
guidelines for drug use
guidelines for drug use
neuronal ceroid-lipofuscinoses
neuronal ceroid-lipofuscinoses
aminopeptidases
aminopeptidases
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
serine proteases
serine proteases
Tripeptidyl-Peptidase 1
Tripeptidyl-Peptidase 1

---
https://www.ema.europa.eu/medicines/human/EPAR/Brineura
2017
false
false
false
United Kingdom
French
English
syndication feed
syndication feed
summary of product characteristics
summary of product characteristics
package leaflet
package leaflet
drug evaluation
drug evaluation
drug approval
drug approval
europe
europe
treatment outcome
recombinant proteins
TPP1 protein, human
TPP1 protein, human
TPP1 protein, human
product surveillance, postmarketing
product surveillance, postmarketing
orphan drug production
orphan drug production
ceroid lipofuscinosis, neuronal, 2
ceroid lipofuscinosis, neuronal, 2
infusions, intraventricular
infusions, intraventricular
infant, newborn
infant, newborn
infant
infant
child
child
drug monitoring
drug monitoring
continuity of patient care
continuity of patient care
drug evaluation, preclinical
drug evaluation, preclinical
drug compounding
drug compounding
cerliponase alfa
cerliponase alfa
neuronal ceroid-lipofuscinoses
aminopeptidases
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
serine proteases
aminopeptidases
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
serine proteases
Tripeptidyl-Peptidase 1
Tripeptidyl-Peptidase 1
Tripeptidyl-Peptidase 1
Tripeptidyl-Peptidase 1

---
Nous contacter.
17/10/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.